# Alternative Antibiotics for Syphilis

> **NCT05069974** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia** · enrollment: 224 (estimated)

## Conditions studied

- Early Latent Syphilis
- Primary Syphilis
- Secondary Syphilis

## Interventions

- **DRUG:** Linezolid 600 mg
- **DRUG:** Benzathine Penicilllin G

## Key facts

- **NCT ID:** NCT05069974
- **Lead sponsor:** Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-14
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069974, "Alternative Antibiotics for Syphilis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05069974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*